Genomic biomarkers of response to nivolumab/ipilimumab (nivo/ipi) and nivolumab (nivo) monotherapy in 108 patients with advanced renal cell carcinoma.Chung‐Han Lee, A. Ari Hakimi, Diego Chowell et al.|Journal of Clinical Oncology|2019Cited by 1